OncoTargets and Therapy
Volume 12, 2019 - Issue
Open access
57
Views
12
CrossRef citations to date
0
Altmetric
Original Research
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy
Muwen Yang1 Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]
, Xingsong Qin1 Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]
, Guangyuan Qin2 Breast Cancer Institute of the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]
& Xinyu Zheng1 Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected];2 Breast Cancer Institute of the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]Correspondence[email protected]
Pages 2171-2180
|
Published online: 25 Mar 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.